Related Experiment Video

Updated: May 29, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

Antifungal vaccine development: where we are, where we are headed

Monika Janeczko1, Konrad Kubiński1, Leszek Wawiórka2

  • 1Department of Molecular Biology Institute of Biological Sciences Faculty of Medicine John Paul II Catholic University of Lublin, Konstantynów 1, H 20-708 Lublin, Poland.

Vaccine
|May 27, 2026
PubMed

Insights

Invasive fungal infections are a major global health threat, especially for immunocompromised patients. Developing an effective antifungal vaccine is crucial to address treatment failures and emerging drug resistance.

Area of Science:

  • Mycology
  • Immunology
  • Vaccinology

Background:

  • Invasive fungal infections (IFIs) cause millions of deaths globally each year.
  • Immunocompromised individuals (e.g., HIV/AIDS, cancer, transplant patients) are disproportionately affected.
  • Current antifungal drugs face resistance and treatment failures, highlighting the need for new strategies.

Purpose of the Study:

  • To review the current landscape of antifungal vaccine research.
  • To bridge the gap between laboratory findings and clinical applications for IFIs.
  • To identify challenges and propose future directions for antifungal vaccine development.

Main Methods:

  • Comprehensive literature review of mechanistic immune responses to fungal pathogens.
  • Analysis of current and emerging vaccine platforms for IFIs.
  • Critical evaluation of biological and technical constraints in antifungal vaccinology.

Main Results:

  • Limited therapeutic options and emerging resistance necessitate novel preventive measures.
  • Existing vaccine strategies face challenges in immunocompromised populations.
  • Emerging approaches like trained immunity and T-cell therapies show promise for this group.

Conclusions:

  • An effective antifungal vaccine is a critical unmet medical need.
  • Novel strategies are required to overcome challenges in vaccinating immunocompromised hosts.
  • Further research into trained immunity and T-cell therapies could lead to breakthrough antifungal vaccines.
Keywords:
Antifungal resistanceAntifungal vaccinesClinical trialsFungal immunityImmunocompromised hostsInvasive fungal infectionsVaccine development

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview